Skip to content
Screener

Indivior Pharmaceuticals, Inc. INDV Interest Income

Interest Income at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$2.29M-3.9%
Alkermes logo
AlkermesALKS
$5.34M-51.8%
TRV
Trevi Therapeutics, Inc.TRVI
$1.7M+50.8%

Segments

By segment

See full
Reportable Segment$3M-25.0%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.56B+66.3%
Enterprise value$4.9B+88.3%
P/E18.2×-7.2×
P/S3.5×+1.2×

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Return on equity-117%—
Debt / equity-3.5×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:02 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028850
Line itemThree Months Ended March 31, 20262025
Total operating expenses139156
Operating income13766
Other (income) and expenses:
Interest (income)(3)(4)
Interest expense712
Loss on debt extinguishment18—
Income before income taxes11559
Income tax expense2611

Item 1. Unaudited Condensed Financial Statements.

FAQ

What is Indivior Pharmaceuticals, Inc.'s interest income?
Indivior Pharmaceuticals, Inc. (INDV) reported interest income of $3M in Q1 2026.
How has Indivior Pharmaceuticals, Inc.'s interest income changed year-over-year?
Indivior Pharmaceuticals, Inc.'s interest income decreased by 25.0% year-over-year, from $4M to $3M.
What is the long-term trend for Indivior Pharmaceuticals, Inc.'s interest income?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s interest income has grown at a 5.0% compound annual growth rate (CAGR), from $19M to $22M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Indivior Pharmaceuticals, Inc.'s interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude